Medications for Peripheral Vascular Diseases

19 results

  • Isoxsuprine hydrochloride (isoxsuprine hydrochloride)

    (isoxsuprine hydrochloride)
    Vedco dba Valdar
    Usage: This drug is possibly effective for relieving symptoms related to cerebrovascular insufficiency and in treating peripheral vascular diseases such as arteriosclerosis obliterans, thromboangitis obliterans (Buerger's disease), and Raynaud's disease. Further research is needed to confirm additional indications.

  • Omniscan (gadodiamide)

    (gadodiamide)
    GE Healthcare Inc.
    Usage: OMNISCAN is a gadolinium-based contrast agent indicated for intravenous use in MRI to visualize lesions with abnormal vascularity in the brain, spine, and associated tissues, as well as in the thoracic (noncardiac), abdominal, pelvic, and retroperitoneal regions.

  • Omniscan (gadodiamide)

    (gadodiamide)
    GE Healthcare Inc.
    Usage: OMNISCAN is a gadolinium-based contrast agent for intravenous use in MRI, indicated for visualizing lesions with abnormal vascularity in the brain, spine, and associated tissues, as well as in the thoracic (noncardiac), abdominal, pelvic, and retroperitoneal regions.

  • Papaverine hydrochloride (papaverine hydrochloride)

    (Papaverine Hydrochloride)
    American Regent, Inc.
    Usage: Papaverine is indicated for conditions involving smooth muscle spasms, including vascular spasms related to acute myocardial infarction, angina pectoris, peripheral and pulmonary embolism, peripheral vascular disease, and certain cerebral angiospastic states, as well as visceral spasms like ureteral, biliary, or gastrointestinal colic.

  • Pentoxifylline (pentoxifylline)

    (Pentoxifylline)
    Oceanside Pharmaceuticals
    Usage: Pentoxifylline Extended-Release Tablets are indicated for treating intermittent claudication due to chronic occlusive arterial disease in the limbs. They can improve symptoms and function but are not substitutes for definitive therapies like surgical bypass or removal of arterial obstructions in peripheral vascular disease.

  • Simvastatin (simvastatin)

    (SIMVASTATIN)
    REMEDYREPACK INC.
    Usage: Simvastatin tablets are indicated to reduce the risk of coronary heart disease-related mortality and events in high-risk adults, and to lower LDL cholesterol in adults with primary hyperlipidemia, heterozygous familial hypercholesterolemia, or as an adjunct to diet for treating dysbetalipoproteinemia and hypertriglyceridemia.

  • Simvastatin (simvastatin)

    (simvastatin)
    REMEDYREPACK INC.
    Usage: Simvastatin is indicated to reduce the risk of coronary heart disease events in high-risk adults, lower LDL cholesterol in patients with primary hyperlipidemia, heterozygous familial hypercholesterolemia (HeFH), and as an adjunct treatment for homozygous familial hypercholesterolemia (HoFH), dysbetalipoproteinemia, and hypertriglyceridemia.

  • Simvastatin (simvastatin)

    (SIMVASTATIN)
    Preferred Pharmaceuticals Inc.
    Usage: Simvastatin tablets are indicated to reduce the risk of coronary heart disease events and mortality in high-risk adults. They also help lower LDL cholesterol in adults with primary hyperlipidemia, adolescents with heterozygous familial hypercholesterolemia, and are used alongside other therapies for patients with homozygous familial hypercholesterolemia.

  • Simvastatin (simvastatin)

    (simvastatin)
    QPharma Inc
    Usage: Simvastatin is indicated for reducing total mortality and coronary heart disease events in high-risk adults, managing low-density lipoprotein cholesterol in primary hyperlipidemia and heterozygous familial hypercholesterolemia, and as an adjunct therapy for homozygous familial hypercholesterolemia, primary dysbetalipoproteinemia, and hypertriglyceridemia.

  • Simvastatin (simvastatin)

    (simvastatin)
    Bryant Ranch Prepack
    Usage: Simvastatin is indicated for reducing the risk of coronary heart disease events and mortality in high-risk adults, lowering LDL cholesterol in primary hyperlipidemia and heterozygous familial hypercholesterolemia, and as an adjunct treatment for homozygous familial hypercholesterolemia, dysbetalipoproteinemia, and hypertriglyceridemia.